Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Abernethy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|December 19, 2003
Infections and anti-TNF therapy: strategies for screening based on clinical experienceC Estrach, V E Abernethy, J K Dawson
British Journal of Rheumatology|January 1, 1997
Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporinJ K Dawson, V E Abernethy, M P Lynch
British Journal of Rheumatology|August 26, 1998
Methotrexate and penicillin interactionJ K Dawson, V E Abernethy, M P Lynch
British Journal of Rheumatology|May 1, 1996
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritisJ K Dawson, E A Campbell, V E Abernethy, et al.
Rheumatology (Oxford, England)|June 27, 2003
Outcome measures for rheumatologistsV V Kaushik, V E Abernethy, M P Lynch, et al.
Thorax|May 1, 1989
Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditionsD J Harrison, R Simpson, R Kharbanda, et al.
Lancet (London, England)|June 29, 1996
A woman who took cod-liver oil and smokedJ K Dawson, V E Abernethy, D R Graham, et al.
BMJ (Clinical Research Ed.)|November 4, 1989
Hepatotoxicity of herbal remediesF B MacGregor, V E Abernethy, S Dahabra, et al.
The Journal of Infection|December 31, 2002
Mycobacterium malmoense septic arthritisS E Whitehead, K D Allen, V E Abernethy, et al.
The American Journal of Physiology|November 24, 1999
Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROSJ Iglesias, V E Abernethy, Z Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|December 19, 2003
Infections and anti-TNF therapy: strategies for screening based on clinical experienceC Estrach, V E Abernethy, J K Dawson
British Journal of Rheumatology|January 1, 1997
Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporinJ K Dawson, V E Abernethy, M P Lynch
British Journal of Rheumatology|August 26, 1998
Methotrexate and penicillin interactionJ K Dawson, V E Abernethy, M P Lynch
British Journal of Rheumatology|May 1, 1996
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritisJ K Dawson, E A Campbell, V E Abernethy, et al.
Rheumatology (Oxford, England)|June 27, 2003
Outcome measures for rheumatologistsV V Kaushik, V E Abernethy, M P Lynch, et al.
Thorax|May 1, 1989
Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditionsD J Harrison, R Simpson, R Kharbanda, et al.
Lancet (London, England)|June 29, 1996
A woman who took cod-liver oil and smokedJ K Dawson, V E Abernethy, D R Graham, et al.
BMJ (Clinical Research Ed.)|November 4, 1989
Hepatotoxicity of herbal remediesF B MacGregor, V E Abernethy, S Dahabra, et al.
The Journal of Infection|December 31, 2002
Mycobacterium malmoense septic arthritisS E Whitehead, K D Allen, V E Abernethy, et al.
The American Journal of Physiology|November 24, 1999
Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROSJ Iglesias, V E Abernethy, Z Wang, et al.
Pageof 2